Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 04 tags : Product-news save search
Certara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates EarlierFirst-of-its-kind software predicts likelihood of off-target safety issues that could impede clinical progress
Published: 2021-05-04 (Crawled : 00:00) - biospace.com/
CERT | $16.19 -4.48% -4.69% 490K
|
|
| O: -0.98%
H: 1.43%
C: -4.23%
software risk drug
Teva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in the United States
Published: 2021-05-04 (Crawled : 16:00) - biospace.com/
TEVA | $12.78 -3.03% -0.24% 9M
|
Health Technology
|
| O: -2.87%
H: 1.52%
C: -3.9%
injection infections
2021 COVID-19 News: Pfizer to File for Full Approval of Its Vaccine and More
Published: 2021-05-04 (Crawled : 15:00) - biospace.com/
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.82%
H: 0.28%
C: -0.06%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.23%
H: 1.83%
C: 1.78%
covid vaccine approval covid-19
Genprex Initiates Site Recruitment for Acclaim-2 Clinical Trial for the Treatment of Non-Small Cell Lung Cancer
Published: 2021-05-04 (Crawled : 14:00) - biospace.com/
GNPX | $2.16 -2.26% -2.31% 17K
|
Health Technology
|
| O: -2.9%
H: 13.04%
C: 0.0%
treatment lung cancer cancer trial
Exelixis Expands its Biotherapeutics Portfolio with Acquisition of GamaMabs Pharma’s First-in-Class Humanized Antibody Program Against a Novel Oncology Target
Published: 2021-05-04 (Crawled : 13:00) - biospace.com/
EXEL | $22.47 -1.75% -1.78% 2.6M
|
Health Technology
|
| O: -0.36%
H: 0.89%
C: -3.49%
acquisition antibody iot
ViiV Healthcare initiates rolling submission of new drug application with US FDA for long-acting cabotegravir for prevention of HIV
Published: 2021-05-04 (Crawled : 13:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.43%
H: 0.43%
C: -0.13%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.19%
H: 0.29%
C: -0.27%
new drug fda drug hiv submission application
Stoke Therapeutics Presents New Data That Demonstrate Tango Antisense Oligonucleotides (ASOs) Increase OPA1 Protein Production and Improve Mitochondrial Function in Cells Derived From Patients With Autosomal Dominant Optic Atrophy (ADOA)
Published: 2021-05-04 (Crawled : 13:00) - biospace.com/
STOK | $11.66 -0.51% -0.51% 1.1M
|
Health Technology
|
| O: -0.44%
H: 1.74%
C: -2.91%
leo
Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: -1.25%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.82%
H: 0.28%
C: -0.06%
XNCR | $18.98 -0.47% -0.47% 470K
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: -5.61%
MOR | $18.02 -0.11% -0.11% 590K
|
Health Technology
|
| O: -4.71%
H: 0.33%
C: -2.65%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: -2.37%
H: 2.04%
C: -2.95%
financial results results
ChromaDex and Ro Partner for New Product Development
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
CDXC | $3.795 -4.41% -4.61% 200K
|
Process Industries
|
| O: 0.46%
H: 1.25%
C: -0.8%
new product
New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
ABCL | $3.92 0.0% 770K
|
|
| O: -0.65%
H: 10.38%
C: 8.4%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.87%
H: 1.36%
C: 0.36%
covid clinical trials antibody trial covid-19
Silence Therapeutics Launches New Video Game to Support International Thalassemia Day and Raise Disease Awareness
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
SLN | $21.98 1.95% 1.91% 120K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
disease
908 Devices and Bio-Techne Announce Joint Collaboration
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
MASS | $5.61 0.36% 0.36% 160K
|
|
| O: -0.25%
H: 0.19%
C: -0.57%
TECH | $62.25 -0.77% -0.77% 1.2M
|
Health Technology
|
| O: -1.19%
H: 0.67%
C: -0.74%
collaboration device
Bio-Techne and 908 Devices Announce Joint Collaboration
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
MASS | $5.61 0.36% 0.36% 160K
|
|
| O: -0.25%
H: 0.19%
C: -0.57%
TECH | $62.25 -0.77% -0.77% 1.2M
|
Health Technology
|
| O: -1.19%
H: 0.67%
C: -0.74%
collaboration device
Repligen Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
RGEN | $157.12 -2.4% -2.46% 750K
|
Health Technology
|
| O: 3.36%
H: 0.0%
C: -9.5%
financial results results
Cytokinetics Announces Cohort 3 of REDWOOD-HCM is Open to EnrollmentNext Cohort to Enroll Patients on Background Therapy of Disopyramide
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
CYTK | $67.0 -1.37% -1.39% 890K
|
Health Technology
|
| O: -1.2%
H: 1.56%
C: -5.31%
therapy enroll
Lilly Outlines Robust Plans to Strengthen ESG Commitments Across the Globe
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.87%
H: 1.36%
C: 0.36%
Plus Therapeutics Announces Key RNL™ Development and cGMP Drug Manufacturing Collaboration Agreements– Agreements are a major step for ongoing clinical trials and future commercial drug supply
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
PSTV | $1.765 -0.57% 6.7K
|
Health Technology
|
| O: 15.77%
H: 17.61%
C: -20.27%
ongoing clinical trials collaboration drug trial chmp
Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Potential Registration Trial of Vidutolimod (CMP-001) in Patients with Anti-PD-1 Refractory Advanced Melanoma
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
CMPI | $10.5 0.0%
|
Health Technology
|
| O: -0.78%
H: 0.0%
C: -3.42%
potential trial
SIGA Announces New Drug Application Filing with FDA for Intravenous Formulation of TPOXX- Important for Patients Who Cannot Swallow Oral Capsules -
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
SIGA | $8.24 -3.17% -3.28% 710K
|
Health Technology
|
| O: -0.27%
H: 1.1%
C: 0.69%
new drug fda drug application
Omeros Corporation Announces Approval of ICD-10 Codes for HSCT-TMA Diagnosis and for Narsoplimab Administration
Published: 2021-05-04 (Crawled : 11:00) - biospace.com/
OMER | $3.22 -3.59% -3.73% 430K
|
Health Technology
|
| O: -0.56%
H: 0.79%
C: -0.23%
approval diagnostic
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.